Asterisk Dental: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Asterisk Dental
Largest movements
- Receivables within one year +€777,419
up €777,419 (+114%), from €680,191 to €1.5m
of which Other amounts receivable: +€764,972
- Deferred charges and accrued income +€739,085
up €739,085 (+123%), from €598,467 to €1.3m
- Accrued charges and deferred income +€1.3m
up €1.3m (+114%), from €1.2m to €2.5m
- Debts after one year +€743,034
up €743,034 (+5.4%), from €13.8m to €14.6m
- Profit (loss) carried forward -€605,603
down €605,603 (-71.9%), from -€842,190 to -€1.4m
- Financial charges +€149,126
up €149,126 (+12.1%), from €1.2m to €1.4m
- Financial income +€140,952
up €140,952 (+23.3%), from €603,698 to €744,650
- Gross operating margin +€96,830
up €96,830, from -€69,550 to €27,279
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €14,195,026 | €15,648,812 | +€1.5m | +10.2% |
| Fixed assets | 21/28 | €12,839,716 | €12,839,716 | = | 0.0% |
| Financial fixed assets | 28 | €12,839,716 | €12,839,716 | = | 0.0% |
| Current assets | 29/58 | €1,355,310 | €2,809,096 | +€1.5m | +107% |
| Amounts receivable within one year | 40/41 | €680,191 | €1,457,609 | +€777,419 | +114% |
| Trade receivables | 40 | €38,710 | €51,157 | +€12,447 | +32.2% |
| Other amounts receivable | 41 | €641,481 | €1,406,452 | +€764,972 | +119% |
| Cash at bank and in hand | 54/58 | €76,652 | €13,935 | -€62,717 | -81.8% |
| Deferred charges and accrued income | 490/1 | €598,467 | €1,337,552 | +€739,085 | +123% |
| Total equity and liabilities | 10/49 | €14,195,026 | €15,648,812 | +€1.5m | +10.2% |
| Equity | 10/15 | -€842,189 | -€1,447,792 | -€605,603 | -71.9% |
| Contributions | 10/11 | €1 | €1 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€842,190 | -€1,447,793 | -€605,603 | -71.9% |
| Amounts payable | 17/49 | €15,037,215 | €17,096,604 | +€2.1m | +13.7% |
| Amounts payable after more than one year | 17 | €13,807,216 | €14,550,250 | +€743,034 | +5.4% |
| Financial debts | 170/4 | €13,807,216 | €14,550,250 | +€743,034 | +5.4% |
| Amounts payable within one year | 42/48 | €79,604 | €79,117 | -€487 | -0.6% |
| Trade debts | 44 | €79,604 | €79,012 | -€592 | -0.7% |
| Suppliers | 440/4 | €79,604 | €79,012 | -€592 | -0.7% |
| Advances received on contracts in progress | 46 | - | €105 | +€105 | |
| Accrued charges and deferred income | 492/3 | €1,150,395 | €2,467,237 | +€1.3m | +114% |
| Other operating charges | 640/8 | €804 | €796 | -€7 | -0.9% |
| Gross operating margin | 9900 | -€69,550 | €27,279 | +€96,830 | |
| Operating profit (loss) | 9901 | -€70,354 | €26,483 | +€96,837 | |
| Financial income | 75/76B | €603,698 | €744,650 | +€140,952 | +23.3% |
| Recurring financial income | 75 | €603,698 | €744,650 | +€140,952 | +23.3% |
| Financial charges | 65/66B | €1,227,610 | €1,376,736 | +€149,126 | +12.1% |
| Recurring financial charges | 65 | €1,227,610 | €1,376,736 | +€149,126 | +12.1% |
| Profit (loss) for the period before taxes | 9903 | -€694,266 | -€605,603 | +€88,663 | +12.8% |
| Profit (loss) for the period | 9904 | -€694,266 | -€605,603 | +€88,663 | +12.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€694,266 | -€605,603 | +€88,663 | +12.8% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.